Medtide Inc. (3880) Receives CSRC Filing Notice for H Share Full Circulation

Bulletin Express
Feb 05

Medtide Inc. announced that, following the acceptance of its H Share Full Circulation application by the China Securities Regulatory Commission (CSRC) on July 27, 2025, a filing notice was issued on February 5, 2026. According to the filing notice, the conversion and listing process may proceed, and if it is not completed within 12 months from the notice’s date, an updated filing with the CSRC will be required.

Details of the conversion and listing plan have not been finalized. The H Share Full Circulation, conversion, and listing remain subject to further procedural requirements by the CSRC, The Stock Exchange of Hong Kong Limited, and other relevant domestic and overseas regulatory authorities. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10